Riber H1 reports increased revenues and margins
MBE firm Riber has posted its results for the first half of 2026 with recorded revenue growth and improved earnings. The company is also continuing to implement its strategic roadmap, having secured €6m in financing to accelerate the industrialisation of ROSIE II.
In what the company described a a complex international environment, it recorded a 19 percent increase in revenues and positive net income for the first half of 2026. This performance was driven by strong momentum in Services and Accessories and resilient Systems sales.
At the same time, Riber is continuing to roll out ROSIE (Riber Oxide Silicon Epitaxy), its platform dedicated to the growth of functional oxides on 300 mm silicon wafers, designed in accordance with SEMI industry standards. The technology targets integrated silicon photonics, with potential applications in electro-optical components for telecoms and data centres, as well as in certain quantum architectures. The second ROSIE system was shipped in July 2026 to a major quantum computing player in the United States.
To support the next stage of ROSIE's development, Riber has secured €6m in bank financing for the industrialisation of ROSIE II, a dual-chamber cluster production platform.
Revenues for the first half of 2026 amounted to €12.7m, up 19 percent compared with the first half of 2025.Systems revenues amounted to €7.7m, down 1 percent from the first half of 2025. Services and Accessories revenues rose 71 percent to €5.1m, against a favorable comparison base.
Given the traditional seasonality of Riber's sales, it says that first-half results cannot be extrapolated to the full year.
Gross margin came to €5.1m, up 31 percent compared with the first half of 2025. The gross margin rate therefore reached 39.8 percent of revenue, compared with 36.2 percent one year earlier.
Operating income was positive at €0.1m, compared with a loss of €0.7m in the first half of 2025. This €0.8m improvement reflects revenue growth, the higher gross margin rate and disciplined operating expense management.
Net income amounted to €0.2m, compared with a loss of €0.8m in the first half of 2025. It includes net financial income of €0.1m.
Shareholders' equity at end-June 2026 stood at €25.7m, compared with €27.3m at year-end 2025. The decrease mainly reflects the result for the period and the €2.1m distribution to shareholders from the issue premium account in June 2026.
Order book at June 30, 2026
Commercial activity remains strong, particularly in applications related to datacom and quantum technologies.
At June 30, 2026, the order book stood at €26.8m, down by 3 percent year on year. It was affected by export restrictions to Asia, which prevented more than €8m in orders from being secured, and by longer decision-making cycles at certain customers.
Systems orders amounted to €16.5m (-27 percent) and comprised orders for 4 systems, including 3 production systems and 1 ROSIE platform. This order book does not include the order announced in July 2026 for a production system in Europe, scheduled for delivery in 2027.
Services and Accessories orders rose sharply to €10.3m (+98 percent), supported in particular by sales of spare parts for recently ordered equipment and several upgrade projects for long-standing customers in North America.
Outlook
Riber is continuing to execute its roadmap with its first ROSIE II production system now under construction. The system will support further technological maturation of the platform, accelerate the qualification of BTO/STO2 processes under industrial operating conditions and prepare the technology for commercial rollout.
Riber may use this first ROSIE II system to produce technology wafers or allocate it to an industrial customer. The first BTO/STO samples developed through the partnership with the Novo Nordisk Foundation Quantum Computing Programme (NQCP) will be available in the fourth quarter of 2026. Several laboratories and industrial companies have confirmed their interest in technology through wafer pre-orders.
In addition, Riber has been invited to participate in the establishment of major industrial and technological partnerships, helping to support the development of new applications.
2026 outlook
Riber says its addressable markets continue to benefit from favourable structural trends, particularly in photonics, artificial intelligence and quantum technologies. The Company also continues to see sustained demand for its Services and Accessories.
Subject to obtaining an export license, Riber expects revenues to be broadly in line with 2025.
Annie Geoffroy, chair and CEO commented:“The first half of 2026 confirms the strength of our core business in an international environment that remains complex. Strong momentum in Services and Accessories, together with sustained interest in our technologies, are encouraging signs.
"We are also reaching an important milestone, with the support of our financial partners, as we move forward with the construction of ROSIE II. This new platform will enable us to accelerate process qualification and prepare for technology’s commercial deployment. At the same time, we are continuing to strengthen our product offering by combining epitaxy and deposition technologies and developing process automation solutions.
"We are therefore continuing to execute our roadmap, with the ambition of strengthening our offering around our established technologies and developing new opportunities in photonics, quantum technologies and advanced deposition technologies.”
